Everest Organics Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.71 Cr
- Company Age 32 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 73.38 Cr
- Satisfied Charges ₹ 118.08 Cr
- Revenue Growth 4.28%
- Profit Growth 176.40%
- Ebitda 1081.61%
- Net Worth -0.81%
- Total Assets 12.32%
About Everest Organics
Everest Organics Limited (EOL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 February 1993 and has a history of 32 years. Its registered office is in Medak, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524790.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.71 Cr.
The company currently has active open charges totaling ₹73.38 Cr. The company has closed loans amounting to ₹118.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Everest Organics Limited India are Ramakrishna Peruri as Cfo, Srikakarlapudi Sirisha as Ceo, and Tanmaya Jena as Company Secretary. Venkata Vadali, Hari Srikakarlapudi, Ramakrishnam Kounparaju, and Three other members serve as directors at the Company.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24230TG1993PLC015426
- Company No.
015426
- Stock Symbol
BSE : 524790
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Feb 1993
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
What products or services does Everest Organics Limited offer?
Everest Organics Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Inorganic Salts, Pharma Ingredients & Raw Materials, Digestive System API, Antacid Drugs, Esomeprazole Drugs, Digestive System Drugs & Medicines, Industrial Chemicals & Supplies, Liquid Phenol, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Everest Organics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srikakarlapudi Sirisha  | Managing Director | 30-Jul-2014 | Current |
| Ramakrishna Peruri | CFO | 28-Sep-2015 | Current |
| Tanmaya Jena | Company Secretary | 29-Nov-2024 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Vadali | Additional Director | 13-Nov-2024 | Current |
| Hari Srikakarlapudi | Whole-Time Director | 29-Sep-2007 | Current |
| Ramakrishnam Kounparaju | Director | 28-Sep-2015 | Current |
Kakarlapudi Raju  | Director | 19-Apr-1995 | Current |
| Sundara Srikakolapu | Director | 01-Sep-2023 | Current |
Financial Performance of Everest Organics.
Everest Organics Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.28% increase. The company also saw a substantial improvement in profitability, with a 176.4% increase in profit. The company's net worth dipped by a decrease of 0.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Everest Organics?
In 2024, Everest Organics had a promoter holding of 74.15% and a public holding of 25.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Everest Life Sciences Private LimitedSrikakarlapudi Sirisha is a mutual person
Charges (Loans)
₹73.38 Cr
₹118.08 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 57.34 Cr
- Canara Bank : 15.00 Cr
- Axis Bank Limited : 0.88 Cr
- Others : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2023 | Canara Bank | ₹15.00 Cr | Open |
| 18 May 2022 | Others | ₹1.67 M | Open |
| 31 Mar 2021 | Axis Bank Limited | ₹6.42 M | Open |
| 28 Dec 2020 | Hdfc Bank Limited | ₹57.34 Cr | Open |
| 18 Mar 2020 | Axis Bank Limited | ₹2.37 M | Open |
How Many Employees Work at Everest Organics?
Everest Organics has a workforce of 387 employees as of Jan 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everest Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everest Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
